Testing intensive atorvastatin to prevent stroke complications with microbleeds
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This study looks at whether high-dose atorvastatin (a cholesterol medicine) can lower the risk of bleeding-related complications in some people after an ischemic stroke. You may be eligible if your brain scan shows tiny “microbleeds,” which can raise bleeding risk.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had a non-cardioembolic ischemic stroke within the last 14 days
- You’re an adult age 18 to 85
- Your brain MRI scan shows cerebral microbleeds on a specific scan type (SWI)
- You (or your legal representative) can sign consent to join the study
- You can safely have CT and MRI scans (no contraindications like certain metal implants)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether high-dose atorvastatin can help protect the artery wall after emergency clot-removal treatment for an acute stroke. It uses a special 3T MRI scan to look for changes in the blood vessels and may lower the risk of future problems if the artery wall is better protected.
This trial compares two medications—cilostazol and aspirin—to see which is better at preventing another stroke in people who have had a recent clot-caused stroke and also have tiny spots of bleeding in the brain (microbleeds). It aims to find a safer and more effective treatment for this specific group.
This trial tests if the statin drug atorvastatin can help people recover from a type of stroke called a brain bleed. It is for adults who have a moderate-sized bleed in the upper part of the brain and can start taking the drug within 48 hours of symptoms.
This trial tests whether a higher-dose statin can help after an ischemic stroke in people who have specific plaque patterns in brain blood vessels. It may help lower the risk of another stroke by targeting the artery plaque process.
This study tests if combining the blood thinner clopidogrel with either atorvastatin or rosuvastatin (both cholesterol-lowering drugs) works better for people who have had a mild first-time stroke in the small blood vessels of the brain. The goal is to find a safe and effective treatment regimen.
This study tests whether adding clopidogrel (a blood thinner) to atorvastatin or rosuvastatin (cholesterol-lowering drugs) helps people who had a first-time large-vessel ischemic stroke. It aims to find the best way to prevent another stroke.
Hear when a new Acute Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.